Related Experiment Video
Updated: Mar 24, 2026
09:03
Optimizing Photoneuromodulation Techniques to Evaluate the Role of Green Light-Emitting Diodes in Pain Management
Published on: March 28, 2025
1.2K
[Melatonin in chronic pain syndromes].
1GBOU VPO 'Pervyj Moskovskij gosudarstvennyj meditsinskij universitet im. I.M. Sechenova', Moskva.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|March 16, 2016
Summary
Melatonin, a neurohormone, shows promise in managing chronic pain conditions like fibromyalgia and arthritis. Its analgesic effects stem from improved sleep and direct interactions with pain pathways.
Area of Science:
- Neuroendocrinology
- Pain Management
- Sleep Medicine
Context:
- Melatonin, a neurohormone, regulates circadian rhythms and exhibits diverse physiological functions.
- Chronic pain syndromes often involve disrupted sleep and circadian rhythms.
- Emerging research suggests melatonin's potential as an analgesic agent.
Purpose:
- To review the current literature on melatonin's efficacy in treating various chronic pain conditions.
- To explore the proposed mechanisms underlying melatonin's pain-relieving properties.
Summary:
- This literature review examines studies on melatonin for fibromyalgia, headache, irritable bowel syndrome, chronic back pain, and rheumatoid arthritis.
- Melatonin's analgesic effects may be attributed to sleep normalization, circadian rhythm regulation, and direct receptor-mediated actions.
- The review discusses how melatonin interacts with neurotransmitter systems to modulate pain perception.
Impact:
- Provides a comprehensive overview of melatonin's role in pain management.
- Highlights potential therapeutic applications of melatonin for patients with chronic pain.
- Suggests avenues for future research into melatonin's mechanisms of action and clinical utility.
Related Concept Videos
01:19Management of Insomnia
767
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
767
01:25Analgesia and Pain Management
2.8K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.8K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
805
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
805
01:07Narcolepsy
736
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
736
01:27Insomnia
571
Insomnia is a prevalent sleep disorder characterized by difficulty falling asleep, frequent awakenings during the night, and waking up too early without being able to return to sleep. People with insomnia often experience these disruptions at least three nights a week for at least one month. Chronic insomnia, which lasts for at least three months, can lead to increased anxiety, which in turn can worsen sleep difficulties, creating a cycle of sleeplessness and stress.
Multiple factors contribute...
Multiple factors contribute...
571
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
1.4K
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
1.4K